Achieving low target pressures with today's glaucoma medications

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In the 21st century there are more highly effective medical management options for glaucoma than there were in the 1980s and 1990s. In deciding among them, the clinician's challenge is to select what is clinically relevant from the large amounts of available data. In evaluating different drugs the clinician must consider not only the mean intraocular pressure (IOP) of a trial population, but also the percentage of patients achieving clinically relevant low IOPs. The consistency of IOP control throughout the day and night is also critical. Other factors such as safety, tolerability, and cost-effectiveness must also be kept in mind, with an awareness (both in human and monetary terms) of the cost of treatment failure. This overview concludes that newer medical regimens for IOP lowering address efficacy and safety issues more successfully than older ones.

Original languageEnglish
JournalSurvey of Ophthalmology
Volume48
Issue number2 SUPPL. 1
DOIs
StatePublished - 2003

Fingerprint

Intraocular Pressure
Glaucoma
Pressure
Safety
Treatment Failure
Cost-Benefit Analysis
Costs and Cost Analysis
Pharmaceutical Preparations
Population

Keywords

  • Glaucoma medications
  • Intraocular pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Achieving low target pressures with today's glaucoma medications. / Cantor, Louis.

In: Survey of Ophthalmology, Vol. 48, No. 2 SUPPL. 1, 2003.

Research output: Contribution to journalArticle

@article{951a23bb9d3b4fc7876c665c34e525b8,
title = "Achieving low target pressures with today's glaucoma medications",
abstract = "In the 21st century there are more highly effective medical management options for glaucoma than there were in the 1980s and 1990s. In deciding among them, the clinician's challenge is to select what is clinically relevant from the large amounts of available data. In evaluating different drugs the clinician must consider not only the mean intraocular pressure (IOP) of a trial population, but also the percentage of patients achieving clinically relevant low IOPs. The consistency of IOP control throughout the day and night is also critical. Other factors such as safety, tolerability, and cost-effectiveness must also be kept in mind, with an awareness (both in human and monetary terms) of the cost of treatment failure. This overview concludes that newer medical regimens for IOP lowering address efficacy and safety issues more successfully than older ones.",
keywords = "Glaucoma medications, Intraocular pressure",
author = "Louis Cantor",
year = "2003",
doi = "10.1016/S0039-6257(03)00009-2",
language = "English",
volume = "48",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Achieving low target pressures with today's glaucoma medications

AU - Cantor, Louis

PY - 2003

Y1 - 2003

N2 - In the 21st century there are more highly effective medical management options for glaucoma than there were in the 1980s and 1990s. In deciding among them, the clinician's challenge is to select what is clinically relevant from the large amounts of available data. In evaluating different drugs the clinician must consider not only the mean intraocular pressure (IOP) of a trial population, but also the percentage of patients achieving clinically relevant low IOPs. The consistency of IOP control throughout the day and night is also critical. Other factors such as safety, tolerability, and cost-effectiveness must also be kept in mind, with an awareness (both in human and monetary terms) of the cost of treatment failure. This overview concludes that newer medical regimens for IOP lowering address efficacy and safety issues more successfully than older ones.

AB - In the 21st century there are more highly effective medical management options for glaucoma than there were in the 1980s and 1990s. In deciding among them, the clinician's challenge is to select what is clinically relevant from the large amounts of available data. In evaluating different drugs the clinician must consider not only the mean intraocular pressure (IOP) of a trial population, but also the percentage of patients achieving clinically relevant low IOPs. The consistency of IOP control throughout the day and night is also critical. Other factors such as safety, tolerability, and cost-effectiveness must also be kept in mind, with an awareness (both in human and monetary terms) of the cost of treatment failure. This overview concludes that newer medical regimens for IOP lowering address efficacy and safety issues more successfully than older ones.

KW - Glaucoma medications

KW - Intraocular pressure

UR - http://www.scopus.com/inward/record.url?scp=10744228958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744228958&partnerID=8YFLogxK

U2 - 10.1016/S0039-6257(03)00009-2

DO - 10.1016/S0039-6257(03)00009-2

M3 - Article

C2 - 12852429

AN - SCOPUS:10744228958

VL - 48

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 2 SUPPL. 1

ER -